{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:20:04Z","timestamp":1791091204810,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf02897262","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T13:31:36Z","timestamp":1209475896000},"page":"147-150","source":"Crossref","is-referenced-by-count":17,"title":["Intrapleural etoposide for malignant effusion"],"prefix":"10.1007","volume":"26","author":[{"given":"Paul Y.","family":"Holoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane G.","family":"Jeffries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari M.","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie A.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meher S.","family":"Engineer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02897262_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00254085","volume":"2","author":"DS Alberts","year":"1979","unstructured":"Alberts DS, Chen HSG, Mayersohn M, Perrier D, Moon TE, Gross JF (1979) Bleomycin pharmacokinetics in man: II. Intracavitary administration. Cancer Chemother Pharmacol 2: 127","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02897262_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cpt196455581","volume":"5","author":"B Clarkson","year":"1966","unstructured":"Clarkson B, O\u2019Connor A, Winston L, Hutchison D (1966) The physiologic disposition of 5-fluorouracil and 5-fluoro-2\u2032-deoxyuridine in man. J Clin Pharmacol Ther 5: 581","journal-title":"J Clin Pharmacol Ther"},{"key":"BF02897262_CR3","first-page":"141","volume":"7","author":"M D\u2019Incalci","year":"1982","unstructured":"D\u2019Incalci M, Farina P, Sessa C, Mangioni C, Conter V, Masera G, Rocchetti M, Brambilla Pisoni M, Piazza E, Beer M, Cavalli F (1982) Pharmacokinetics of VP-16-123 given by different administration methods. Cancer Chemother Pharmacol 7: 141","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02897262_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00254537","volume":"7","author":"WE Evans","year":"1982","unstructured":"Evans WE, Sinkule JA, Crom WR, Dow L, Look AT, Rivera G (1982) Pharmacokinetics of teniposide (VM-26) and etoposide (VP-16-213) in children with cancer. Cancer Chemother Pharmacol 7: 147","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02897262_CR5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1172\/JCI110130","volume":"67","author":"SB Howell","year":"1981","unstructured":"Howell SB, Chu BBF, Wung WE, Metha BM, Mendelsohn J (1981) Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. J Clin Invest 67: 1161","journal-title":"J Clin Invest"},{"key":"BF02897262_CR6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF00434360","volume":"14","author":"JM Jones","year":"1985","unstructured":"Jones JM, Olman EA, Egorin MJ, Aisner J (1985) A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide. Cancer Chemother Pharmacol 14: 172","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02897262_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mpo.2950130406","volume":"13","author":"M Markman","year":"1985","unstructured":"Markman M, Cleary S, King ME, Howell SB (1985) Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions. Med Pediatr Oncol 13: 191","journal-title":"Med Pediatr Oncol"},{"key":"BF02897262_CR8","first-page":"1903","volume":"66","author":"MJ Ostrowski","year":"1982","unstructured":"Ostrowski MJ, Halsall GM (1982) Intracavitary bleomycin in the management of malignant effusions: a multicenter study. Cancer Treat Rep 66: 1903","journal-title":"Cancer Treat Rep"},{"key":"BF02897262_CR9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF01059549","volume":"8","author":"S Riegelman","year":"1980","unstructured":"Riegelman S, Collier P (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 8: 509","journal-title":"J Pharmacokinet Biopharm"},{"key":"BF02897262_CR10","first-page":"3109","volume":"44","author":"JA Sinkule","year":"1984","unstructured":"Sinkule JA, Hutson P, Hayes A, Etcubanas E, Evans W (1984) Pharmacokinetics of etoposide (VP-16) in children and adolescents with refractory solid tumors. Cancer Res 44: 3109","journal-title":"Cancer Res"},{"key":"BF02897262_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archinte.1965.03870030111019","volume":"116","author":"LG Suhrland","year":"1968","unstructured":"Suhrland LG, Weisberger AS (1968) Intracavitary 5-fluorouracil in malignant effusions. Arch Intern Med 116: 431","journal-title":"Arch Intern Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02897262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02897262\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02897262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T17:30:34Z","timestamp":1558546234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02897262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF02897262"],"URL":"https:\/\/doi.org\/10.1007\/bf02897262","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}